The store will not work correctly when cookies are disabled.
3-(Biphenyl-3-yl)-6-(thien-3-yl)imidazo[1,2-a]pyridine
ID: ALA2393020
PubChem CID: 71699304
Max Phase: Preclinical
Molecular Formula: C23H16N2S
Molecular Weight: 352.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(-c2cccc(-c3cnc4ccc(-c5ccsc5)cn34)c2)cc1
Standard InChI: InChI=1S/C23H16N2S/c1-2-5-17(6-3-1)18-7-4-8-19(13-18)22-14-24-23-10-9-20(15-25(22)23)21-11-12-26-16-21/h1-16H
Standard InChI Key: CQTLRPKYPWEYCL-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 30 0 0 0 0 0 0 0 0999 V2000
16.8377 -20.8507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8365 -21.6703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5446 -22.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5428 -20.4419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2514 -20.8471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2517 -21.6703 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0346 -21.9245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5183 -21.2583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0342 -20.5926 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2870 -22.6987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7386 -23.3061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9907 -24.0826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7909 -24.2529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3384 -23.6405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0833 -22.8664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1312 -22.0816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3849 -21.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8376 -22.3555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2457 -23.0636 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.0451 -22.8942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1378 -23.8059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3923 -24.5836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1915 -24.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7369 -24.1410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4776 -23.3615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6790 -23.1982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
7 10 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 16 2 0
2 16 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
14 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.46 | Molecular Weight (Monoisotopic): 352.1034 | AlogP: 6.40 | #Rotatable Bonds: 3 |
Polar Surface Area: 17.30 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 5.91 | CX LogP: 5.40 | CX LogD: 5.39 |
Aromatic Rings: 5 | Heavy Atoms: 26 | QED Weighted: 0.37 | Np Likeness Score: -1.62 |
References
1. Enguehard-Gueiffier C, Musiu S, Henry N, Véron JB, Mavel S, Neyts J, Leyssen P, Paeshuyse J, Gueiffier A.. (2013) 3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues, novel Flaviviridae inhibitors., 64 [PMID:23665801] [10.1016/j.ejmech.2013.03.054] |